In Focus

Insurtech funding doubles to $16b but deals shrink

Insurtech funding doubles to $16b but deals shrink

Investment value jumped in 2025 even as transactions dropped to 166.

In Focus

Chemical shares trail MSCI World as margins keep sliding

Review of almost 700 firms shows revenue added 4.3 pts to TSR, but margins cut returns by 3.5 pts.

In Focus

China vehicle exports to surge 20% as domestic sales shrink

EV exports are forecast to grow 40% despite weak early-year sales.

In Focus

IPO market rebounds to $2.54b in 2025, driven by ‘blockbuster’ REITs

Deloitte highlights two secondary listings, regulatory reforms.

In Focus

Hong Kong small retailers step up investment to take on big chains

They are getting a boost from state funding and fee cuts.

Exclusive

Sri Lankan insurers brace for 2025 profit squeeze as non-motor losses mount

Low retention and strong reinsurance keep most rated credit profiles intact.

In Focus

APAC insurers lag with legacy systems despite 87% claim digital lead

The legacy constraint rate rises from 90% at $1b to $5b firms.

In Focus

Chinese insurers' earnings recover as Fitch cites tighter commission controls

Major insurers report YoY earnings improvements despite ongoing tariff and trade tensions.

In Focus

Taiwan life insurers face rising risk in $32b FX mismatch

Fitch warns that spreading FX gains over bond life does not reduce the sector's actual exposure.

In Focus

Can China’s $140b motor insurance market survive a 70% loss ratio?

Loss ratios surged from 57% to 70% in four years as NEV repair costs and parts prices spiked.

In Focus

Hong Kong regulator guts insurance referral fees with 50% cap

Unlicensed third-party referrers previously captured up to 95% of commissions through hidden rebate structures.

Exclusive

Japan and China to spearhead 27 GW global nuclear restart

Wood Mackenzie identifies the two Asian giants as the primary catalysts for the upcoming power surge.

In Focus

Financial planning rises as 63% cite uncertainty, Prudential says

Thailand stands out: 70% choose higher-risk investing, and 68% prefer short-term instruments.

In Focus

Capital rules force Indian insurers to curb aggressive discounting

Aggressive discounting for short-term market share becomes harder to justify.

Exclusive

Zurich Indonesia speeds up claims after Bali floods

Faster settlement boosts confidence in insurance as a practical financial tool.

Exclusive

Seven in 10 APAC insurers expect private equity returns to rise

The survey covers APAC insurers managing $3.82t in assets, Clearwater Analytics said.

In Focus

Human microbiome drugs market to be valued at $2.13b by 2031

By end users, the hospitals & clinics segment held the largest market share in 2024.

In Focus